Want to create an interactive transcript for this episode?
Podcast: CME
Episode: When Topicals Fail: The New IPC Consensus Every Clinician Should Know
Description:
Faculty: Linda Stein Gold, MD
Faculty: Bruce Strober, MD, PhD
This podcast reviews the International Psoriasis Council (IPC) 2025 guidance on reclassifying psoriasis severity and redefining failure of topical therapies. Clinical features such as high-impact disease sites, failure of topical treatment, or BSA >10% all factor into whether patients are candidates for systemic therapy in this new guidance. Despite broad endorsement, many clinicians remain uncertain about applying the new framework. This activity aims to raise awareness, clarify updated criteria, and align practice with current evidence supporting earlier use of IL-23 and IL-17 inhibitors in appropriate patients.